Careful Truss, remember his big "discovery" of 320 (one died lol). plus we should remember the 4 in pilot prior to trial start. So in fact 324 patients in OA alone.
So 1. GvHD P1 (15) 2. MEND (15 est.) 3. DFU (30) 4. OA (324) 5. GvHD P2 (20 est.) as 3 recruited in March in just 3 weeks, and start of trials always slower. 6. Renal (16 to be recruited but cells are already manufactured of course)
Looking around 420 as we speak.
Note: Mesoblast have only done 1 single arm trial in GvHD in over 10 years (54) Children Cynata will surpass this number by end of year, if not by October in GvHD 15 + 60 (75) Adults
Cynata has officially treated more Adult GvHD patients in proper US trials than Mesoblast.
so agree "Don't let the truth get in the way of your story though."
CYP Price at posting:
33.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)